Walvax Biotechnology Co., Ltd. (300142)
Market Open
11 Aug, 06:57
XSHE XSHE Primary ¥
13. 29
+0.16
+1.2186%
¥
19.85B Market Cap
- P/E Ratio
0.01% Div Yield
27.92M Volume
- Eps
¥ 13.13
Previous Close Want to track 300142 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Walvax Biotechnology Co., Ltd. (300142) Statistics
Valuation metrics
Market Cap 19.85B
Enterprise value 21.45B
Trailing P/E (ttm) 73.57
Forward P/E -
PEG ratio 0.61
Price/Sales (ttm) 8.79
Price/Book (mrq) 2.84
Enterprise Value/Revenue 8.97
Enterprise Value/EBITDA 34.93
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 47.46M
Average volume (90 days) 78.72M
Price summary
52-Week low 10.88
52-Week high 16.23
Beta -
50-Day moving average 12.72
200-Day moving average 12.63
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.15
Trailing annual dividend yield 0.0118%
5-Year annual dividend yield -
Payout ratio 0.18
Dividend Date 24 Jun 2026
Ex-Dividend Date 24 Jun 2026
Last split factor 30:10
Last split Date 14 Oct 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.5
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.61
Total debt (mrq) -
Total Debt/Equity (mrq) 0.19
Current ratio (mrq) 2.16%
Book value per share (mrq) 4.89
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
